Eye Disease

News Eye Disease

• Provence Technologies and Neuroptis Biotech partner to develop a new compound for treating dry eye syndrome

  Provence Technologies announced the further strengthening of their collaboration for transferring the chemical development of Neuroptis Biotech’s drug candidate, ML7, and producing the first GMP batches before the end of 2012. ML7 is a drug candidate for the treatment of dry eye syndromes. It is the more

• Oxford BioMedica Announces Research and Development Collaboration for Glaucoma

  Oxford BioMedica plc announced that it has entered into a research and development collaboration with Mayo Clinic, Rochester (USA) to develop a novel gene therapy for the treatment of chronic glaucoma. Under the terms of the agreement, Mayo Clinic and Oxford BioMedica will undertake pre-clinical stu more

• Santhera Announces Intent To File Marketing Authorization Application for Leber's Hereditary Optic Neuropathy

  Santhera Pharmaceuticals announced that it has formally notified the European Medicines Agency of its intent to file for Leber's Hereditary Optic Neuropathy (LHON). In the recent RHODOS study, Catena® showed consistent superiority over placebo and, in particular, improved or protected visual acuity more

Publications Eye Disease

• eyeGENE®: A Vision Community Resource Facilitating Patient Care and Paving the Path for Research through Molecular Diagnostic Testing

  Abstract Molecular genetics and genomics are revolutionizing the study and treatment of inherited eye diseases. In recognition of the impact of molecular genetics on vision and ophthalmology, the National Eye Institute established the National Ophthalmic Disease Genotyping and Phenotyping Networ more

• Marine Drugs, Vol. 11, Pages 960-974: Astaxanthin Attenuates the Apoptosis of Retinal Ganglion Cells in db/db Mice by Inhibition of Oxidative Stress

  Diabetic retinopathy is a common diabetic eye disease caused by changes in retinal ganglion cells (RGCs). It is an ocular manifestation of systemic disease, which affects up to 80% of all patients who have had diabetes for 10 years or more. The genetically diabetic db/db mouse, as a model of type-2 more

• TearLab® Osmolarity System for diagnosing dry eye

  Dry eye (DE) disease is an impairment of the lachrymal unit function and one the most frequent eye problems. A major challenge is to find accurate diagnostic criteria to be able to define DE severity, as symptoms poorly correlate with clinical signs. Tear osmolarity is considered a key factor in DE more

Market studies Eye Disease

• Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2012

  Introduction GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2012" provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on K more

• Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Keratoconjunctivitis sicca (Dry Eye), complete with latest upd more

• Diquas (Dry Eye Syndrome) – Analysis and Forecasts to 2022

  Introduction GlobalData’s pharmaceuticals report, “Diquas (Dry Eye Syndrome) – Analysis and Forecasts to 2022” provides Diquas sales forecasts for Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales perf more

Websites Eye Disease